# Samtasu Post-marketing General Drug Use-results Survey in Patients with Volume Overload in Heart Failure.

> **NCT05712746** · — · RECRUITING · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 1600 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Samtasu for I.V. infusion

## Key facts

- **NCT ID:** NCT05712746
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-03
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-05-31
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05712746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05712746, "Samtasu Post-marketing General Drug Use-results Survey in Patients with Volume Overload in Heart Failure.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05712746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*